BARC:LSEBarclays PLC Analysis
Data as of 2026-05-26 - not real-time
£445.80
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Barclays is trading at £445.8, comfortably above its 20‑day (£430.6), 50‑day (£418.5) and 200‑day (£420.9) simple moving averages, signalling short‑term strength. The RSI of 58 suggests the stock is not overbought, while a bullish MACD (line = 3.04, signal = 1.80) and a positive histogram reinforce upward momentum, though volume is trending downwards. Support sits around £409 and resistance near £454.8, offering a clear upside corridor of roughly 20 % as indicated by the upside/downside metric. Valuation appears attractive: a trailing PE of 10.4 versus an industry average of 16.8, a price‑to‑book of 0.96 and an upside potential of about 21 % suggest the stock is undervalued. The dividend yield of 1.9 % with a modest payout ratio of 20 % looks sustainable given ample cash reserves, despite a high absolute debt level. However, the 30‑day volatility of 32 % and recent geopolitical headlines about Middle‑East tensions inject short‑term risk, and the decreasing volume hints at waning trader enthusiasm. The beta of 0.76 points to lower market‑wide sensitivity, and the extreme‑greed sentiment index (91.8) may be inflating expectations. In summary, the technical set‑up is bullish, fundamentals are solid and valuation is cheap, but investors should watch geopolitical developments and the tapering of trading interest.
Given these dynamics, a cautious but optimistic stance is warranted: hold the current position while monitoring the support level and news flow, and consider adding on dips if the stock respects its technical base and the macro backdrop stabilises.
Given these dynamics, a cautious but optimistic stance is warranted: hold the current position while monitoring the support level and news flow, and consider adding on dips if the stock respects its technical base and the macro backdrop stabilises.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD and price above key SMAs
- Decreasing volume and elevated 30‑day volatility
- Geopolitical tension in the Middle East affecting sentiment
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued valuation metrics (PE, PB) relative to peers
- Attractive dividend yield with low payout ratio
- Upside potential of ~21% and resilient earnings outlook
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong capital returns and solid ROE
- Sustainable dividend and cash generation capacity
- Low beta indicating defensive characteristics in a diversified portfolio
Key Metrics & Analysis
Financial Health
Revenue Growth3.90%
Profit Margin26.77%
P/E Ratio10.4
ROE9.55%
ROA0.44%
P/B Ratio1.0
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI58.2
Support£409.10
Resistance£454.75
MA 20£430.63
MA 50£418.48
MA 200£420.91
MACDBullish
VolumeDecreasing
Fear & Greed Index91.8
Valuation
Target Price£539.25
Upside/Downside20.96%
GradeUndervalued
TypeBlend
Dividend Yield1.93%
Risk Assessment
Beta0.76
Volatility32.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.